Carlo Castellani

Istituto Giannina Gaslini — Italy

Medicine · Health Sciences

45h-index9.1kcitations242works12.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(173), Neonatal Respiratory Health Research(78), Tracheal and airway disorders(61), Congenital Ear and Nasal Anomalies(13), Immunodeficiency and Autoimmune Disorders(10)

Publications241 total

Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis and Rare <i>CFTR</i> Variants: In Vitro Translation to a Phase 3, Double-Blind, Randomized, Placebo-controlled Trial and Real-World Study
American Journal of Respiratory and Critical Care Medicine·2026Open Access
Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor: An Overview of Bioanalytical Methods
Therapeutic Drug Monitoring·2025
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR
Frontiers in Pharmacology·2025Open Access
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant
PLoS ONE·2025· 1 citedOpen Access
Fibrosi cistica e alcalosi metabolica
Medico e Bambino·2025
<i>In silico</i> , <i>in vitro and ex vivo</i> characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators
British Journal of Pharmacology·2025· 2 citedOpen Access
WS13.01Characterization of two novel F508del-CFTR complex alleles and their impact on drug responsiveness
Journal of Cystic Fibrosis·2025Open Access
Primary Lung Tumors in Children: Insights from a Single-Center Case Series
Journal of Clinical Medicine·2025· 4 citedOpen Access
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices
Pharmaceutics·2025· 5 citedOpen Access
Critical Issues in the Management of CRMS/CFSPID Children: A National Real‐World Survey
Pediatric Pulmonology·2025· 3 citedOpen Access
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators
Frontiers in Pharmacology·2024· 3 citedOpen Access
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study
Life·2024· 4 citedOpen Access
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study
Preprints.org·2024· 1 citedOpen Access
Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA
European Respiratory Journal·2024· 13 citedOpen Access
Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union
Journal of Cystic Fibrosis·2024· 5 citedOpen Access
Cystic fibrosis
Nature Reviews Disease Primers·2024· 128 cited
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study
Frontiers in Endocrinology·2024· 3 citedOpen Access
WS02.04 Elexacaftor/tezacaftor/ivacaftor improved lung function and reduced exacerbations among individuals with rare, FDA-approved, CFTR variants in the United States
Journal of Cystic Fibrosis·2024
Standards for the care of people with cystic fibrosis (CF); Planning for a longer life
Journal of Cystic Fibrosis·2024· 24 citedOpen Access
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders
Journal of Cystic Fibrosis·2024· 21 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

À. Munck(11), Kevin W Southern(11), Isabelle Sermet‐Gaudelus(7), B.M. Assael(7), Silvia Gärtner(7), G. Mastella(7), Philip M. Farrell(6), Milan Maçek(6), Martin Schwarz(6), Garry R. Cutting(5), N. Kashirskaya(5), Alan R Smyth(5), Pavel Dřevı́nek(5), Mary Corey(5), Harry Cuppens(5), Claude Férec(5), Emmanuelle Girodon(5), Pier Franco Pignatti(5), J.S. Elborn(5), Cristina Bombieri(5)